Synjardy is a prescription medication combining empagliflozin (12.5mg) and metformin hydrochloride (1000mg) in film-coated tablet form. This combination therapy is manufactured by Boehringer Ingelheim and comes in a pack of 60 tablets for the treatment of type 2 diabetes mellitus. This medication contains two active ingredients that work together to help control blood sugar levels in adults with type 2 diabetes - empagliflozin (a SGLT2 inhibitor) and metformin hydrochloride (a biguanide). The tablets are film-coated for oral administration and should be taken as prescribed by a healthcare provider, typically twice daily with meals. This is a prescription-only medication that requires regular medical monitoring.